Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer

Clinical trial NCT01989780 · COMPLETED

Trial details

NCT number: NCT01989780
Sponsor: Japan Breast Cancer Research Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2014-01-01
Primary completion: 2018-06-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.